Bioventus Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $0.22 | $0.22 | +0.0% | Beat |
| Q12026 FY2026 | $0.09 | $0.15 | +66.7% | Beat |
| Q42025 FY2025 | $0.22 | $0.24 | +9.1% | Beat |
Back to BVS overview · BVS holders · BVS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.